Drug Shortage Report for TARO-BUDESONIDE
Report ID | 173505 |
Drug Identification Number | 02494264 |
Brand name | TARO-BUDESONIDE |
Common or Proper name | BUDESONIDE |
Company Name | TARO PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | BUDESONIDE |
Strength(s) | 0.125MG |
Dosage form(s) | SUSPENSION |
Route of administration | INHALATION |
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
Additional packaging sizes | 2 |
ATC code | R03BA |
ATC description | OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-04-14 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2025-01-28 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 130 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v50 | 2025-01-28 | French | Compare |
v49 | 2025-01-28 | English | Compare |
v48 | 2025-01-07 | French | Compare |
v47 | 2025-01-07 | English | Compare |
v46 | 2024-12-13 | French | Compare |
v45 | 2024-12-13 | English | Compare |
v44 | 2024-11-11 | French | Compare |
v43 | 2024-11-11 | English | Compare |
v42 | 2024-09-09 | French | Compare |
v41 | 2024-09-09 | English | Compare |
v40 | 2024-06-14 | French | Compare |
v39 | 2024-06-14 | English | Compare |
v38 | 2024-05-09 | French | Compare |
v37 | 2024-05-09 | English | Compare |
v36 | 2024-05-07 | French | Compare |
v35 | 2024-05-07 | English | Compare |
v34 | 2024-01-05 | French | Compare |
v33 | 2024-01-05 | English | Compare |
v32 | 2023-08-16 | French | Compare |
v31 | 2023-08-16 | English | Compare |